![]() |
Figure 8: Collagen IV deposition. ELISA was performed on cell-scaffold matrix
samples for wild type fibroblasts (panel a) and diabetic fibroblasts (panel
b) at days 1, 6, and 14 to determine protein levels of collagen IV (col IV). a) Collagen IV concentration (pg col IV/ug total protein) for wild type (wt) fibroblasts in NF and NF+MMP scaffolds at days 1, 6 and 14. Collagen IV levels at day 1 were higher in NF than in NF+MMP scaffolds and decreased with time, indicating ECM remodeling. b) Collagen IV concentration (pg col IV/ug total protein) for diabetic (db) fibroblasts in NF and NF+MMP scaffolds at days 1, 6 and 14. Collagen IV levels were highest at day 1 in NF scaffolds, with no effect of exogenous MMP-2 (NF+MMP). Expression levels were normalized using total protein content as measured using Bradford assay. + p<0.05 when compared to NF samples, ^p<0.05 when compared to day 1 samples of same experimental group. |